Dr. Margot J. Burnell

Claim this profile

Regional Health Authority B, Zone 2

Studies Breast Cancer
Studies Cancer
2 reported clinical trials
4 drugs studied

Area of expertise

1Breast Cancer
Margot J. Burnell has run 2 trials for Breast Cancer. Some of their research focus areas include:
HER2 positive
ER positive
ER negative
2Cancer
Margot J. Burnell has run 1 trial for Cancer. Some of their research focus areas include:
HER2 positive
ER positive
ER negative

Affiliated Hospitals

Image of trial facility.
Regional Health Authority B, Zone 2
Image of trial facility.
Atlantic Health Sciences Corporation-Saint John Regional Hospital

Clinical Trials Margot J. Burnell is currently running

Image of trial facility.

T-DM1 + Tucatinib

for Breast Cancer

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria

More about Margot J. Burnell

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Margot J. Burnell has experience with
  • Fulvestrant
  • Ipatasertib
  • Trastuzumab Emtansine
  • Tucatinib
Breakdown of trials Margot J. Burnell has run
Breast Cancer
Cancer

Other Doctors you might be interested in

Samantha L. GrayAtlantic Health Sciences Corporation-Saint John Regional Hospital
Farah NazAtlantic Health Sciences Corporation-Saint John Regional Hospital
James MichaelAtlantic Health Sciences Corporation-Saint John Regional Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margot J. Burnell specialize in?
Margot J. Burnell focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Margot J. Burnell currently recruiting for clinical trials?
Yes, Margot J. Burnell is currently recruiting for 1 clinical trial in Saint John New Brunswick. If you're interested in participating, you should apply.
Are there any treatments that Margot J. Burnell has studied deeply?
Yes, Margot J. Burnell has studied treatments such as Fulvestrant, Ipatasertib, Trastuzumab Emtansine.
What is the best way to schedule an appointment with Margot J. Burnell?
Apply for one of the trials that Margot J. Burnell is conducting.
What is the office address of Margot J. Burnell?
The office of Margot J. Burnell is located at: Regional Health Authority B, Zone 2, Saint John, New Brunswick E2L 4L2 Canada. This is the address for their practice at the Regional Health Authority B, Zone 2.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top